We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Efforts to Eliminate Conflict-of-Interest Waivers Threatens Advisory Committee System
FDA: Efforts to Eliminate Conflict-of-Interest Waivers Threatens Advisory Committee System
May 19, 2006
The FDA opposes lawmakers’ efforts to limit the agency’s
ability to grant conflict-of-interest waivers for advisory committee members, arguing that such a move would undermine its ability to have the necessary expert advice needed to make drug policy, an agency official says.